252 related articles for article (PubMed ID: 12663596)
21. Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience.
Lapolla A; Dalfrà MG; Spezia R; Anichini R; Bonomo M; Bruttomesso D; Di Cianni G; Franzetti I; Galluzzo A; Mello G; Menato G; Napoli A; Noacco G; Parretti E; Santini C; Scaldaferri E; Scaldaferri L; Songini M; Tonutti L; Torlone E; Gentilella R; Rossi A; Valle D
Acta Diabetol; 2008 Mar; 45(1):61-6. PubMed ID: 18227964
[TBL] [Abstract][Full Text] [Related]
22. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.
Ahmed AB; Home PD
Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967
[TBL] [Abstract][Full Text] [Related]
23. Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving beta-cell function at onset of type 1 diabetes mellitus.
Recasens M; Aguilera E; Morínigo R; Casamitjana R; Nicoletti F; Gomis R; Conget I
Diabetes Res Clin Pract; 2003 Jun; 60(3):153-9. PubMed ID: 12757987
[TBL] [Abstract][Full Text] [Related]
24. Progression of diabetic retinopathy during pregnancy in women with type 2 diabetes.
Rasmussen KL; Laugesen CS; Ringholm L; Vestgaard M; Damm P; Mathiesen ER
Diabetologia; 2010 Jun; 53(6):1076-83. PubMed ID: 20225131
[TBL] [Abstract][Full Text] [Related]
25. Is insulin lispro safe in pregnant women: Does it cause any adverse outcomes on infants or mothers?
Aydin Y; Berker D; Direktör N; Ustün I; Tütüncü YA; Işik S; Delibaşi T; Guler S
Diabetes Res Clin Pract; 2008 Jun; 80(3):444-8. PubMed ID: 18359121
[TBL] [Abstract][Full Text] [Related]
26. Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands.
Evers IM; de Valk HW; Mol BW; ter Braak EW; Visser GH
Diabetologia; 2002 Nov; 45(11):1484-9. PubMed ID: 12436330
[TBL] [Abstract][Full Text] [Related]
27. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis.
Della Manna T; Steinmetz L; Campos PR; Farhat SC; Schvartsman C; Kuperman H; Setian N; Damiani D
Diabetes Care; 2005 Aug; 28(8):1856-61. PubMed ID: 16043723
[TBL] [Abstract][Full Text] [Related]
28. Treatment of type 1 diabetes with insulin lispro during Ramadan.
Kadiri A; Al-Nakhi A; El-Ghazali S; Jabbar A; Al Arouj M; Akram J; Wyatt J; Assem A; Ristic S
Diabetes Metab; 2001 Sep; 27(4 Pt 1):482-6. PubMed ID: 11547222
[TBL] [Abstract][Full Text] [Related]
29. Safety of insulin lispro: pooled data from clinical trials.
Glazer NB; Zalani S; Anderson JH; Bastyr EJ
Am J Health Syst Pharm; 1999 Mar; 56(6):542-7. PubMed ID: 10192689
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes.
Brunelle BL; Llewelyn J; Anderson JH; Gale EA; Koivisto VA
Diabetes Care; 1998 Oct; 21(10):1726-31. PubMed ID: 9773738
[TBL] [Abstract][Full Text] [Related]
31. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.
Attia N; Jones TW; Holcombe J; Tamborlane WV
Diabetes Care; 1998 May; 21(5):817-21. PubMed ID: 9589247
[TBL] [Abstract][Full Text] [Related]
32. Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients.
Rave K; Heise T; Pfützner A; Heinemann L; Sawicki PT
Diabetes Care; 2001 May; 24(5):886-90. PubMed ID: 11347749
[TBL] [Abstract][Full Text] [Related]
33. Use of insulin glargine during pregnancy: a case-control pilot study.
Price N; Bartlett C; Gillmer M
BJOG; 2007 Apr; 114(4):453-7. PubMed ID: 17261126
[TBL] [Abstract][Full Text] [Related]
34. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus.
Wilde MI; McTavish D
Drugs; 1997 Oct; 54(4):597-614. PubMed ID: 9339963
[TBL] [Abstract][Full Text] [Related]
35. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
Diabetes Control and Complications Trial Research Group
Diabetes Care; 2000 Aug; 23(8):1084-91. PubMed ID: 10937502
[TBL] [Abstract][Full Text] [Related]
36. Insulin lispro: its role in the treatment of diabetes mellitus.
Campbell RK; Campbell LK; White JR
Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
[TBL] [Abstract][Full Text] [Related]
37. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy.
Evers IM; ter Braak EW; de Valk HW; van Der Schoot B; Janssen N; Visser GH
Diabetes Care; 2002 Mar; 25(3):554-9. PubMed ID: 11874946
[TBL] [Abstract][Full Text] [Related]
38. Optimal provision of daytime NPH insulin in patients using the insulin analog lispro.
Ahmed AB; Home PD
Diabetes Care; 1998 Oct; 21(10):1707-13. PubMed ID: 9773735
[TBL] [Abstract][Full Text] [Related]
39. Insulin lispro: a review of its use in the management of diabetes mellitus.
Simpson D; McCormack PL; Keating GM; Lyseng-Williamson KA
Drugs; 2007; 67(3):407-34. PubMed ID: 17335298
[TBL] [Abstract][Full Text] [Related]
40. Use of glargine insulin before and during pregnancy in a woman with type 1 diabetes and Addison's Disease.
Dolci M; Mori M; Baccetti F
Diabetes Care; 2005 Aug; 28(8):2084-5. PubMed ID: 16043769
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
